Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fenoldopam for prevention of splanchnic ischemia during cardiopulmonary bypass
2008-000818-78Phase 2Completed
- Sponsor
- Policlinico San Donato
- Start
- Apr 2009
- Modality
- Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of fenoldopam in bowel ischemia, lactic acidosis, acute kidney failure (AKF) and 4 more, sponsored by Policlinico San Donato. Primary endpoint: Incidence of lactic acidosis. Started Apr 2009; status: completed.
02
Drugs
fenoldopam
03
Conditions
bowel ischemialactic acidosisacute kidney failure (AKF)Cardiovascular Malformation (CVM)coronary arteriosclerosis
Beyond the preview
Go deeper on 2008-000818-78.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-000818-78.